mTBI Identification and Monitoring Through Retinal Scanning
NCT: NCT06142435 · RECRUITING
Brief Summary
Rebion has developed a device, the Rebion trauma tool (referred to as the head and intraocular trauma tool, or "HITT"), that detects ocular fixation and alignment using a binocular retinal scan. Preliminary data obtained from hospitalized patients with a clinically-confirmed traumatic brain injury (TBI) and uninjured controls indicates that the device can detect changes in ocular fixation, alignment, and saccades that are related to brain injury. This study seeks to evaluate the ability of the Rebion trauma tool to assess perturbations in eye movements resulting from TBI. The study will enroll 60 TBI patients and 20 controls.
Frequently Asked Questions
What is mTBI Identification and Monitoring Through Retinal Scanning?
mTBI Identification and Monitoring Through Retinal Scanning is a clinical trial registered under NCT06142435. Current status: RECRUITING.
What is the status of NCT06142435?
The current status of NCT06142435 (mTBI Identification and Monitoring Through Retinal Scanning) is: RECRUITING.
When did mTBI Identification and Monitoring Through Retinal Scanning start?
mTBI Identification and Monitoring Through Retinal Scanning started on 2023-08-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.